Agonist binding to K 2 -adrenoceptors is modulated by a number of factors such as Mg 2 and Na ions and by experimental manipulations which interfere with receptor^G-protein-coupling such as pertussis toxin pre-treatment or the presence of guanine nucleotides. Agonist binding assays may therefore offer an opportunity to make inferences, albeit indirect, about receptor states or conformations and about the molecular nature of the processes involved in receptor activation. We have investigated possible differences in the effects of Na ions on the binding of agonists to the three human K 2 -adrenoceptor subtypes, K 2A , K 2B and K 2C , recombinantly expressed in S115 mouse mammary tumour cells. NaCl (40 mM) influenced the apparent affinity of a panel of K 2 -adrenoceptor ligands in a complex compound-and subtype-dependent manner. Sodium ions affected both high-and low-affinity conformations of the receptors, as defined by co-incubation with 10 WM 5P-guanylylimidodiphosphate (Gpp(NH)p). The effects of NaCl and Gpp(NH)p on agonist binding were additive indicating different modes of action for the two allosteric modulators. Thus, quite marked differences between closely related receptor subtypes were noted in the molecular details of agonist^receptor interactions and in the integration of allosteric modulation by Na ions. Possible explanations for the experimental findings are discussed within the theoretical framework of multistate models, and a proposal is presented for a potential physiological role of the modulatory effect of Na ions, where intracellular Na concentrations would direct the activating influence of receptors to different G-proteins. ß 1998 Elsevier Science B.V. All rights reserved.
Introduction
K 2 -Adrenoceptors belong to the family of G-protein-coupled receptors (GPCR). Three human K 2 -adrenoceptor subtype genes, K 2 -C10, K 2 -C4 and K 2 -C2, have been cloned [1^3] and assigned to the pharmacologically de¢ned receptor subtypes K 2A , K 2C and K 2B [4] . The coupling of receptors to guanine nucleotide regulatory proteins (G-proteins) has been investigated intensively due to its pivotal role in signal transduction.
The conceptualisation of GPCR function at the molecular level has seen signi¢cant changes in recent years. Classically, receptors were viewed as essentially static entities which underwent conformational changes from inactive (or resting) to activated states only after being triggered by an agonist. However, this notion of receptors as agonist-activated switches is di¤cult to reconcile with experimental observations indicating receptor activity in the absence of agonists.
A more recent concept regards GPCR as dynamic entities, in which binding interactions between closely situated amino acid residues and peptide domains are constantly formed or broken and which therefore constantly undergo spontaneous conformational changes. This enables the receptor protein to occasionally access activated conformations even in the absence of agonists. The role of ligands in this concept is viewed more as one of stabilising receptor conformations rather than triggering their formation.
A number of multi-state models with varying degrees of sophistication have been presented in the literature (for a summary see Kenakin [5] ). The simplest of them, the so-called two-state model, requires only three parameters to describe a receptor system: the a¤nities of a ligand for the activated and resting state, respectively, and an equilibrium constant corresponding to the ratio of receptors in the resting state over those in the activated state in the absence of any ligand [6] . Proposals for multiple state receptor models have often been motivated by attempts to account for shallow or even heterogeneous agonist competition binding curves. However, as has been pointed out by Lee et al. [7] in a theoretical analysis of the ternary complex model, such derivations from Langmuirian adsorption isotherms can not be explained by multi-state models as long as complete interconversion between states is assumed. An essentially identical conclusion has been drawn by Neubig et al. [8] based on experimental data for the K 2 -adrenoceptor in human platelets. The latter authors also demonstrated that the heterogeneous binding properties of platelet K 2 -adrenoceptors were best modelled by dividing the receptor population into a couplable and a noncouplable subset.
Agonist binding to K 2 -adrenoceptors has been shown to be a¡ected by a number of factors such as Mg 2 and Na ions and by experimental manipulations which interfere with receptor^G-proteincoupling such as pertussis toxin pre-treatment or the presence of guanine nucleotides. Agonist binding assays may therefore allow indirect inferences to be made about receptor states and conformational changes.
Sodium ions modulate agonist binding to a number of GPCR. In the case of the porcine K 2A -adrenoceptor the allosteric e¡ect of Na has been ascribed to interactions with a speci¢c residue (Asp 79) located on the cytoplasmic face of the second transmembrane domain [9] . This aspartate is conserved in all three human K 2 -adrenoceptor subtypes, as well as in most other GPCR [10^12], and modulation by Na ions has been shown for a number of K 2 -adrenoceptor preparations [12^20] . The existence of a highly conserved aspartate residue in many GPCRs together with the widespread occurrence of allosteric modulation by Na ions can be taken as an indication for a physiological role of this phenomenon. In this regard it is relevant to mention that manipulation of the intracellular Na concentration has been shown to modulate agonist a¤nity of K 2 -adrenoceptors present on intact human platelets [14] .
The current study utilised recombinant human K 2 -adrenoceptor subtypes (K 2A , K 2B , K 2C ) expressed in S115 mouse mammary tumour cells. One purpose of the study was to investigate possible di¡erences in the e¡ects of Na ions on the binding of agonists to the three human K 2 -adrenoceptor subtypes. Such differences between closely related receptor subtypes may shed light on the molecular details of agonistr eceptor interactions and the integration of allosteric modulation by Na ions in that process. A second goal was to try to gain insight into the mode of action of allosteric modulation by Na ions by viewing the phenomenon from the perspective of the dynamic receptor concept.
Materials and methods

Cell culture and preparation of cell homogenates
Recombinant lines of Shionogi 115 (S115) mouse mammary tumour cells stably expressing the human K 2 -adrenoceptor subtypes K 2A , K 2B and K 2C (K 2 -C10, K 2 -C2 and K 2 -C4) [21, 22] were cultured in roller bottles (1400 cm 2 , Nunclon) in DMEM (Dulbecco's modi¢ed Eagle's medium) supplemented with 20 mM Hepes, 20 mM NaHCO 3 , 5% heat-inactivated foetal calf serum, 100 U/ml penicillin, 50 Wg/ml streptomycin, 1 mM sodium pyruvate and 10 nM testosterone.
The cells were grown in 5% CO 2 at 37³C. Cells were harvested into chilled phosphate-bu¡ered saline, pelleted and stored frozen at 370³C; the stability of the receptors has been previously demonstrated [22] . Cell pellets were washed twice before experiments with incubation bu¡er (NMDG: 25 mM glycylglycine; 40 mM Hepes; 5 mM EGTA; 10 mM MgCl 2 ; 75 mM N-methyl-D-glucamine (NMDG); pH 7.4, or NMDG+NaCl: 25 mM glycylglycine; 40 mM Hepes; 5 mM EGTA; 10 mM MgCl 2 ; 35 mM NMDG; 40 mM NaCl; pH 7.4). Cells were pelleted by centrifugation (42 000Ug, 15 min) at 4³C and then homogenised with an Ultra-Turrax homogeniser (15 s) in ice-cold incubation bu¡er, and pelleted again by centrifugation (42 000Ug, 15 min) at 4³C. The pellet was resuspended in ice-cold incubation bu¡er just before use and rehomogenised. The osmolality of the binding medium was thus held constant in the presence and absence of 40 mM NaCl with 35 or 75 mM NMDG Cl 3 bu¡er. In some experiments, 40 mM LiCl or KCl were used instead of 40 mM NaCl. Protein concentrations were determined with the method of Bradford [23] with bovine serum albumin as the reference standard.
Binding assays
All incubations were performed in triplicate in a 25³C water bath with shaking. Receptor binding was measured by incubating 100 Wl of cell homogenate (30^90 Wg of protein) with the radioligand [ 3 H]RX821002 in a total volume of 250 Wl in the absence (75 mM NMDG) or presence of 40 mM NaCl (35 mM NMDG). After 30 min, the incubations were terminated by dilution with 2 ml of icecold bu¡er and rapid ¢ltration through glass ¢bre ¢lters (Whatman GF/B) using a Brandel M-48R (Gaithersburg, MD, USA) cell harvester in a cold room (6³C). The ¢lters were washed twice with 5 ml of ice-cold bu¡er and placed into scintillation vials with OptiPhase`HiSafe' III (Wallac, Turku, Finland) for counting at 45% e¤ciency (Wallac 1410, Wallac). Speci¢c binding was de¢ned as the di¡erence between total and non-speci¢c binding determined in parallel sets of tubes but in the presence of an excess of (3)-adrenaline (100 WM).
For kinetic studies of the association reaction, cell homogenates were incubated with 
Calculations
Equilibrium dissociation constants (K d ) and receptor densities (B max ) were calculated from the results of saturation experiments using computer-assisted data analysis with the EBDA-LIGAND package (Elsevier Biosoft, Cambridge, UK), a non-linear least squares computer program (McPherson, 1985) . Association and dissociation data were analysed with the KINETIC module of the LIGAND program package. Inhibition constants (K i ) for competing drugs were calculated with GraphPAD programs (Graph-PAD Software and PRISM, San Diego, CA, USA) applying the Cheng^Pruso¡ equation [26] . Agonist competition curves in the absence of Gpp(NH)p were analysed assuming a two-site binding model, although the ¢t was not always statistically signi¢-cantly better to this model than to a one-site model. One-site models were used for results obtained in the presence of Gpp(NH)p, as two-site analysis did not provide statistically signi¢cantly better ¢ts than onesite models (F-test).
The K d -and K i -values are presented as geometric means þ S.E. and the other results as arithmetic means þ S.E. Student's t-test with two-tailed proba-bilities, or one-way analysis of variance (ANOVA) together with the Student^Newman^Keuls-test were used to test the statistical signi¢cance of the observed di¡erences between group means.
Drugs and chemicals
[ 3 H]RX821002 (speci¢c activity 48 Ci/mmol) was from Amersham (Buckinghamshire, UK). Dexmedetomidine and L-medetomidine were gifts from OrionFarmos (Turku, Finland). Rauwolscine was from Carl Roth (Karlsruhe, Germany), and RX821002 (2-[2-(2-methoxy-1,4-benzodioxanyl)]imidazoline hydrochloride), UK 14,304 (5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine) and K-methylnoradrenaline were from Research Biochemicals (Natick, MA, USA). The following compounds were obtained from Sigma (St. Louis, MO, USA):
-noradrenaline, clonidine, NMDG and 5P-guanylylimidodiphosphate (Gpp-(NH)p). NaCl was from Merck (Darmstadt, Germany). Cell culture reagents were supplied by Gibco (Gaithersburg, MD, USA). Other chemicals were of analytical or reagent grade, and were purchased from commercial suppliers.
Results
Saturation binding
Equilibrium dissociation constants (K d ) and estimates of receptor density (B max ) were determined with [ 3 H]RX821002 in NMDG bu¡er in the absence and presence of NaCl (40 mM) and Gpp(NH)p (10 WM). The a¤nities of all three human K 2 -adrenoceptor subtypes for the antagonist radioligand [ 3 H]RX821002 were increased in the presence of 40 mM NaCl. The increase in a¤nity was 1.5-fold for K 2A (P = 0.13), 3.5-fold for K 2B (P 6 0.01) and 3-fold for K 2C (P 6 0.01). Gpp(NH)p tended to increase the a¤nity of K 2A for [ 3 H]RX821002 in the presence of NaCl (P 6 0.01) and reduced the a¤nity of K 2B for the radioligand (P 6 0.01 in the presence of NaCl but not statistically signi¢cant in the absence of NaCl) ( Table 1 ). The Na -induced increase in the a¤nity of K 2C for the radioligand was similar in the absence and presence of Gpp(NH)p (P 6 0.01). Statistically signi¢cant changes were not noted in the B max values. Other monovalent cations (Li , K ) had no e¡ects on the a¤nity (K d ) of the K 2A -subtype for [ 3 H]RX821002 (data not shown). 
Competition with [ 3 H]RX821002 binding
The e¡ects of Na on agonist interactions with recombinant human K 2 -adrenoceptor subtypes were ¢rst evaluated by performing competition binding assays with the radioligand [ 3 H]RX821002 at concentrations close to its K d at each receptor subtype. The competition binding curves of the four to seven tested K 2 -adrenoceptor agonists at the three receptor subtypes were usually best modelled by two-site ¢ts, and showed shallow slopes in one-site models (Hill number 6 1) ( Table 2 ). In the presence of Gpp(NH)p agonist competition results were analysed using both one-site and two-site models. Two-site models did not provide statistically signi¢cantly better ¢ts than one-site models; therefore, only one-site a¤nity constants (K i ) are given in Table 2 for the Gpp(NH)p experiments. As shown in Table 2 and Fig. 1 , the ability of Na to decrease the binding a¤nity of (3)-noradrenaline was quite marked at all three receptor subtypes. High and low a¤nity agonist binding states were equally a¡ected. The effects were largest at the K 2A -subtype. The proportions of high a¤nity binding sites were not in£uenced by Na ; instead, the biphasic competition curves were shifted to the right in a parallel fashion, resulting in larger K iH and K iL values. At K 2A -adrenoceptors, NaCl also potently decreased the a¤nity of other catecholamine agonists. In contrast, the a¤n-ities of clonidine and dexmedetomidine were slightly increased. The a¤nity of L-medetomidine was not in£uenced by NaCl, and the a¤nity of UK 14,304 was somewhat decreased. At K 2B -adrenoceptors, the a¤nity of (3)-noradrenaline was reduced by Na to a clearly lower extent than at K 2A -adrenoceptors, and the a¤nities of dexmedetomidine and UK 14,304 were markedly reduced. Clonidine binding was only marginally a¡ected, as shown in Table 2 . At K 2C -adrenoceptors, the a¤nity of dexmedetomidine was clearly reduced by Na , whereas the a¤nities of (3)-noradrenaline and UK 14,304 were only modestly decreased. Clonidine binding at K 2C -adrenoceptors was not in£uenced by NaCl. The potency order of monovalent cations to decrease the a¤nity of (3)-noradrenaline binding to K 2A -adrenoceptors was Na EK s Li (data not shown). The tendency to biphasic competition by the agonists for [ 3 H]RX821002 binding (in NMDG or NMDG+NaCl) was abolished in the presence of 10 WM Gpp(NH)p. The high-a¤nity components of the competition binding curves were shifted signi¢cantly to the right, and the slopes of the curves were clearly steeper compared to experiments with agonists in the absence of Gpp(NH)p (Fig. 1) . The e¡ects of Na ions and Gpp(NH)p on (3)-noradrenaline binding to K 2 -adrenoceptors appeared to be additive: the curves were shifted to the right in a parallel fashion by Na , whereas Gpp(NH)p abolished the high-af¢nity component (Fig. 1) . When the dependence of the binding of a ¢xed concentration of (3)-noradrenaline (2.7 WM, su¤cient to reduce speci¢c [ 3 H]RX821002 binding by 75% in the absence of Na and by 50% in the presence of 40 mM Na ) on the concentration of Gpp(NH)p was investigated at K 2A -adrenoceptors, similar log-linear relationships were found both in the absence and presence of Na (Fig. 2) . The e¡ects of Na and the guanine nucleotide thus appeared to be additive.
Kinetic studies
In order to ensure that the observed di¡erences in the Na sensitivity of (3)-noradrenaline binding to K 2 -adrenoceptor subtypes were not simply related to the assay conditions, and to elucidate the mechanism of the Na e¡ect, some kinetic experiments were also performed. Addition of (3) . Actually, the reduction in the a¤n-ity of (3)-noradrenaline was largest when the increase in the a¤nity of [ 3 H]RX821002 was smallest, i.e., at K 2A -adrenoceptors (Tables 1 and 2, Fig. 3 ).
Discussion
The interaction of agonists with GPCR is one of the central aspects of signal transduction across plasma membranes. Radiolabelled ligands o¡er a useful means to probe this interaction and a wealth of information has been obtained by this approach. It has become clear that agonist binding is a complex phenomenon susceptible to allosteric modulation by factors such as Mg 2 and Na ions. In addition, it is sensitive to experimental manipulations which a¡ect the interaction of receptors with G-proteins. Based on a vast body of evidence it is now generally accepted that GPCRs exist in at least two di¡erent forms, distinguishable by their a¤nity for agonists. The agonist high-a¤nity binding sites are believed to represent ternary complexes consisting of agonist, activated receptor and guanine nucleotide-free Gprotein while the low-a¤nity agonist binding sites are equated with resting receptor forms.
In the current paper we have sought to further characterise the role of Na ions in the interaction of agonists with three recombinant human K 2 -adrenoceptor subtypes in S115 cells. Considerable di¡er-ences in the percentage of receptor able to assume agonist high-a¤nity forms were noted. Whereas over 50% of the K 2A -adrenoceptors in S115-C10 cells displayed high a¤nity for the physiological ligand, the full agonist (3)-noradrenaline, the proportions were only about 15^27% for the K 2B -and K 2C -subtypes. The presence of a low-a¤nity component in agonist competition binding curves under equilibrium conditions argues that not all receptors can simultaneously couple to G-proteins. Since the number of G-proteins usually exceeds the number of receptors, the reason for this fairly generally observable lack of coupling capacity' is not clear. It may have its origin in a microdomain compartmentation of signal transduction components or in a competition for the pool of available G-proteins by other receptors. The conceptually simplest way to deal with the lack of coupling capacity is to consider the receptor population as consisting of two di¡erent subpopulations, an uncouplable and a couplable one [8] .
In the case of the K 2B -adrenoceptor in S115-C2 cells, the low percentage of couplable receptor may be a consequence of the signi¢cantly higher receptor expression level in S115-C2 (2.8 pmol/mg protein) compared to S115-C10 cells (0.4 pmol/mg protein). For the K 2C -subtype, a relatively high receptor number in the S115-C4 cells (1.2 pmol/mg protein) may not be the only reason for the low degree of coupling compared to S115-C10 cells. In S115 cells, as also previously observed in transfected COS-7 and HEK293 cells [27] , K 2C -adrenoceptors have immunocytochemically been localised not only to the cell membrane but also to intracellular structures (T. Olli-La «hdesma «ki, J. Kallio, M. Scheinin, unpublished data). Such intracellularly localised receptors may have less access to G-proteins than those in the plasma membrane, and may consequently be even more restricted in their ability to form ternary complexes.
Because of the relatively low coupling capacity of the K 2B -and the K 2C -adrenoceptors and the consequently larger variability in the experimental results, the discussion will mainly focus on the K 2A -subtype. Interestingly, the di¡erence among the three K 2 -adrenoceptor subtypes in terms of percentages of coupled receptor was paralleled by di¡erent sensitivities to modulation by Na ions. This pattern is in agreement with Na ions preferentially a¡ecting the agonist high-a¤nity forms of K 2 -adrenoceptors. However, Na ions did not only shift the high-a¤n-ity portion but also the low-a¤nity portion of the agonist competition curves to the right (Fig. 1AĈ ). If it is accepted that the low-a¤nity segment of the competition curves represents uncouplable receptor, then this obviously means that Na ions modulate the receptor also in the absence of any coupling to G-proteins.
In the competition of [ 3 H]RX821002 binding by (3)-noradrenaline (Fig. 1A^C) , both Gpp(NH)p and Na ions caused a reduction in agonist a¤nity. The e¡ects appeared to be at least additive, since the presence of both agents promoted a larger decrease in a¤nity than either of the two alone. Additivity of e¡ects was also observed when increasing concentrations of Gpp(NH)p were tested in combination with 40 mM NaCl (Fig. 2) . That the`uncoupling' e¡ects of Na and Gpp(NH)p are mediated via di¡erent mechanisms can also be inferred from the data in Table 2 , according to which the same percentage of receptor is accumulated in the form of high-a¤nity agonist sites, independent of whether 40 mM NaCl is present or not. The di¡erence between no Na and 40 mM Na is that higher agonist concentrations are required in the presence of Na ions. In other words, the e¡ect of the Na ions can be overcome by increasing the agonist concentration. For Gpp(NH)p that was not the case. The unsurmountable suppression of agonist high-a¤nity binding by guanine nucleotides is considered to be due to an acceleration in the turnover of ternary complexes, resulting in lower steady-state levels of such complexes. At high enough guanine nucleotide concentrations, the lifetime of ternary complexes is so short and their concentration is so low that essentially all receptors appear to exist in the agonist low-a¤nity form. Since the`uncoupling' e¡ect of Na ions is qualitatively di¡erent from that of Gpp(NH)p, it follows that Na does not act via such an acceleration of ternary complex turnover.
The fact that at large enough agonist concentrations the high-a¤nity binding component is restored in the presence of Na furthermore shows that Na does not prevent the formation of ternary complexes; rather, it makes their formation more di¤cult. For a number of GPCR, such as, e.g., the porcine K 2A -adrenoceptor [9] , the modulatory e¡ect of Na has been linked to an aspartate residue in transmembrane domain 2, i.e., the e¡ect is localised in the receptor protein itself. Taking all these points together makes it tempting to speculate that Na may act by impeding the spontaneous conversion of receptor from the agonist low-a¤nity (resting) to the agonist high-a¤nity (activated) state. A very similar hypothesis has been put forward for the formyl peptide receptor in HL60 cells [28] for which the authors suggested that Na might act by preventing the activation of G-proteins by unoccupied receptors.
The hypothesis would smoothly integrate the welldocumented e¡ects of Na on spontaneous and receptor-mediated GTPase or GTPQS-binding activity. In both types of assays Na ions are known to reduce basal activity and to lower agonist potency. If the assumption is made that receptor-mediated effects are directly proportional to the fraction of receptor in the activated state, then the simplest form of the dynamic receptor concept, the two-state model, can be used to predict functional responses of GPCRs [6] . One of the predictions of the two-state model is that basal activity should be proportional to the term 1/(1+L) with L being the equilibrium constant for the spontaneous equilibrium between activated and resting receptor state, L = [R]/[R*]. The observation that Na reduces basal receptor activity argues that it does so by increasing L, i.e., by favouring the resting (agonist low-a¤nity) state R over the activated (agonist high-a¤nity) state R*. A second prediction of the two-state model describes the EC 50 of the receptor-mediated function by Eq. 1
where K A represents the dissociation constant for the resting state and K Ã A the dissociation constant for the activated state. Since K Ã A is smaller than K A , the term 1+L grows faster than the term 1+L(K Ã A /K A ) when L increases. Consequently, an increase in L is accompanied by an increase in the EC 50 , i.e., by a loss of potency. Both the reduction of basal activity and the loss of agonist potency caused by Na in GTPase and GTPQS-binding assays can therefore be interpreted as manifestations of the same underlying mechanism, which is a dampening e¡ect of the cation on spontaneous receptor activation. Indeed, if two assumptions are accepted, ¢rstly, that the Na e¡ect is localised in the receptor rather than the G-protein(s), and secondly, that the two-state model is at least qualitatively applicable, then this interpretation follows automatically from the e¡ect of Na on basal activity. The potency-lowering e¡ect of Na represents complementing evidence which is circumstantial in nature, because the equation for the EC 50 contains K A and K Ã A in addition to the equilibrium constant L. While the e¡ects of Na on the G-protein responses can be fully accommodated by an increase in L, a concomitant change of K A or K Ã A cannot be excluded. In fact, when the agonist binding results in Table 2 are taken into consideration, it becomes necessary to postulate an e¡ect of Na on one or both of these dissociation constants. The reason is that if Na would solely increase the ligandindependent parameter L, the agonist a¤nity lowering e¡ect of Na would be expected to be observed for all agonists. However, as the results in Table 2 (K 2A -subtype) shows, this was not uniformly the case. While Na increased the single-site ¢t K i s and the K iH s for (3)-adrenaline, (3)-noradrenaline, K-methylnoradrenaline and UK 14,304, those for dexmedetomidine and clonidine were unchanged or slightly decreased. The binding results therefore argue that the Na e¡ect contains a ligand-dependent component, for which K A or K Ã A , either one or both, are the obvious candidates. When the equilibrium between resting and activated receptor state is considered in the form of a reaction coordinate, in which the two states are represented by their energy levels, an argument can be deduced, according to which Na actually should be expected to a¡ect either one or both of the dissociation constants K A and K Ã A . The position of the equilibrium between the two receptor states is determined by the di¡erence of their energy levels. As evidenced by their dampening e¡ects on basal GTPase or GTPQS-binding activity, Na ions in£uence this equilibrium in the absence of any ligand. Obviously, this must mean that Na a¡ects the di¡erence between the energy levels by shifting either one or both of them. The energy levels in the reaction coordinate, however, are expressions of certain receptor structures. Thus, when the energy level of one of the states changes, the receptor structure embodied in it must change, which may result in a change in ligand a¤nity for that state.
This line of reasoning touches on the important point that the activated and resting receptor states should not be thought of as two ¢xed three-dimensional receptor structures. Rather, the two states should be considered as the averaged representation of all of their corresponding conformations with the population densities of these conformations playing the role of weighing factors. It should be noted that the two-state model is a simpli¢ed outline of the potentially enormously complex dynamic receptor concept. In principle, any combination of amino acid residue interactions in a receptor, with a ¢nite lifetime, has to be considered as a separate receptor conformation. A complete theoretical description of how a ligand interacts with a receptor would therefore require information about the spontaneous distribution of the whole receptor population among all possible conformations plus the knowledge of the a¤nities of the ligand for all of these conformations. The fact that in most cases adequate descriptions of experimental binding data can be obtained by assuming the existence of only one or two receptor states or binding sites, respectively, is probably mainly a re£ection of a lack of analytical resolution. Conceivably, many receptor conformations are not discriminated by a given ligand because they involve di¡er-ences in the interactions of amino acid residues which do not play a role in the binding of that ligand. Other sets of conformations may give rise to a¤nity di¡erences, but as long as they are small with respect to the resolution of available experimental techniques, they will go undetected.
In summary, the e¡ects of Na ions on agonist binding to human K 2 -adrenoceptors presented in this paper and the well-documented e¡ects of the cation on G-protein functions in GTPase-and GTPQS-binding assays can be accommodated by the hypothesis that Na modulates the energy landscape of receptor conformations, thereby favouring or disfavouring certain receptor conformations. Like many other GPCR, K 2 -adrenoceptors are known to couple to several signal pathways. It may well be possible that di¡erent receptor conformations are involved in the activation of these separate pathways. In this context it is highly interesting to note that in the porcine K 2A -adrenoceptor the replacement by targeted mutagenesis of the same amino acid residue which has been linked to the modulatory e¡ect of Na (Asp79), does lead to the selective loss of receptor coupling to one of the three pathways activated by the wild-type receptor, i.e., K channel activation [29] . Reasoning by analogy, we would therefore like to propose that the physiological role of receptor modulation by Na ions might consist in signal traf¢cking.
